Hermetica Superfood Encyclopedia
The Short Answer
MMST delivers silicon as a monomeric organosilicon molecule that is orally absorbed, raises fasting serum and urinary silicon concentrations, and supports neocollagenesis by promoting collagen cross-linking within the extracellular matrix. A double-blind, randomized, placebo-controlled crossover trial in 22 healthy pre-menopausal women demonstrated statistically significant increases in both fasting serum silicon and urinary silicon excretion at 10.5 mg Si/day over four weeks (P ≤ 0.003 for both endpoints).
CategoryMineral
GroupMineral
Evidence LevelPreliminary
Primary Keywordmonomethylsilanetriol silicon supplement
Monomethylsilanetriol Silicon — botanical close-up
Health Benefits
**Connective Tissue Support**
Silicon from MMST promotes neocollagenesis by stabilizing the hydroxylation of proline and lysine residues in procollagen, thereby strengthening tendons, ligaments, cartilage, and the broader extracellular matrix architecture.
**Bone Matrix Quality**
Silicon participates in bone mineralization by cross-linking collagen fibrils within the osteoid matrix, with MMST-delivered silicon shown to improve the organic framework upon which hydroxyapatite crystals deposit, potentially supporting bone density over time.
**Skin, Hair, and Nail Health**
Oral and topical MMST has been reported to improve measurable skin parameters and the structural integrity of nails and hair, consistent with silicon's role in glycosaminoglycan synthesis and keratin organization, though large controlled trials are limited.
**Superior Bioavailability over Polymeric Silicon**
MMST is absorbed as a monomeric species and accounts for approximately 50% of the measured increase in fasting serum silicon post-supplementation, making it bioavailability-comparable to orthosilicic acid (OSA) and substantially superior to polymerized silica sources such as silicic acid polymers or food-derived silicon.
**Aluminum Detoxification**
Silicon, including that delivered by MMST, forms stable hydroxyaluminosilicate complexes in the gastrointestinal tract and systemically, facilitating urinary excretion of aluminum and reducing tissue aluminum burden, which is of particular interest in neurodegenerative risk contexts.
**Topical Dermal Penetration**
When formulated in cream or gel vehicles, MMST has demonstrated the ability to penetrate the stratum corneum and reach viable epidermis and dermis, providing a targeted route for localized collagen support and skin hydration independent of oral dosing.
Origin & History
Natural habitat
Monomethylsilanetriol (MMST) is a synthetic organosilicon compound developed through modern pharmaceutical chemistry rather than extracted from a natural botanical source. It was formulated to deliver silicon in a monomeric, water-soluble organic form that overcomes the bioavailability limitations of dietary silicon found in plant foods such as whole grains, root vegetables, and drinking water. Commercial production involves controlled chemical synthesis and stabilization for incorporation into oral liquid supplements and topical dermal preparations.
“Silicon has been recognized as a trace element important for connective tissue integrity since the pioneering animal research of Edith Carlisle and Klaus Schwarz in the 1970s, which demonstrated that silicon-deficient diets in rats and chicks produced severe skeletal and connective tissue deformities, establishing silicon as an essential element in vertebrate biology. Dietary silicon from plant-based foods, particularly whole grains and root vegetables, has been consumed throughout human history without deliberate supplementation, and silicon-rich mineral waters have traditionally been associated with longevity and bone health in European spa culture, particularly in France, Belgium, and Germany. MMST itself emerged as a pharmaceutical and nutraceutical ingredient in the latter decades of the twentieth century, designed by organosilicon chemists to provide a more bioavailable and stable oral delivery system than inorganic silica or food silicon, and it gained regulatory recognition in Europe as a novel food ingredient under EFSA oversight. The compound's use for aluminum detoxification has roots in the neurochemical research of Christopher Exley and colleagues, who demonstrated that silicon-rich waters reduce aluminum absorption and brain aluminum burden, giving MMST a secondary clinical identity in the context of aluminum-related neurotoxicity concerns.”Traditional Medicine
Scientific Research
The most rigorous available evidence for MMST is a double-blind, randomized, placebo-controlled crossover trial enrolling 22 healthy pre-menopausal women aged 22–38, which confirmed statistically significant increases in fasting serum silicon and 24-hour urinary silicon at a dose of 10.5 mg Si/day over four weeks (P ≤ 0.003), establishing pharmacokinetic proof of absorption but finding no significant differences in subjective health, well-being, quality of life, or standard serum biochemistry versus placebo. A separate clinical investigation reported improvements in skin surface parameters, nail quality, and hair characteristics alongside evidence of aluminum detoxification following oral MMST use, though detailed sample sizes, blinding status, and effect-size statistics were not fully characterized in available sources. No large-scale, long-term randomized controlled trials examining hard clinical endpoints such as fracture incidence, validated bone mineral density change, or dermatological disease outcomes have been identified for MMST specifically. The overall body of evidence is limited in volume and restricted primarily to pharmacokinetic and biomarker endpoints, warranting conservative interpretation of efficacy claims pending larger and longer-duration studies.
Preparation & Dosage
Traditional preparation
**Oral Liquid Solution**
5 mg elemental silicon per day as MMST, typically delivered in a stabilized aqueous solution; this represents the maximum recommended daily dose per EFSA novel food guidance
The clinically studied dose is 10..
**Topical Cream or Gel**
MMST is incorporated into dermal formulations at concentrations sufficient to penetrate the stratum corneum; specific topical concentrations vary by manufacturer, and standardization to percent MMST content should be confirmed on product labeling.
**Duration**
Clinical trials have assessed safety and pharmacokinetics over four-week supplementation periods; longer-term continuous use is practiced commercially but lacks robust long-term trial support.
**Timing**
Oral MMST is typically administered with or without food, though fasting conditions were used in the pharmacokinetic trial to measure baseline serum silicon changes; no specific food interaction guidance has been established.
**Standardization**
5 mg Si/day corresponds to approximately 21 mg of MMST given its silicon content by molecular mass
Supplement labels should specify elemental silicon content (mg Si) rather than MMST molecular weight alone; 10..
**Comparison to OSA**
For practitioners choosing between forms, MMST and orthosilicic acid (OSA) demonstrate comparable serum silicon elevation at equivalent elemental silicon doses; choice may be guided by formulation stability and tolerability preferences.
Nutritional Profile
MMST is a pure organosilicon compound and does not contribute meaningful macronutrients, calories, or classical micronutrients to the diet; its nutritional relevance is confined entirely to its silicon content. At the maximum recommended dose of 10.5 mg Si/day, MMST provides elemental silicon in a monomeric organic form with estimated bioavailability comparable to stabilized orthosilicic acid, substantially exceeding the low fractional absorption of dietary silicon from whole grains (estimated at 2–4%) or silicic acid polymers. Average dietary silicon intake in Western populations ranges from 20–50 mg/day primarily from cereals and water, placing the supplemental dose of 10.5 mg Si within a physiologically relevant range. No fat-soluble cofactors or specific nutrient interactions are required for MMST absorption, though adequate hydration supports urinary silicon excretion, which is the primary elimination route.
How It Works
Mechanism of Action
Silicon delivered via MMST exerts its biological effects primarily by acting as a cofactor in the enzymatic hydroxylation of proline and lysine by prolyl hydroxylase and lysyl hydroxylase, reactions essential for stable triple-helix formation in collagen types I, II, and III; without adequate silicon, these cross-links are weakened and collagen turnover is impaired. At the molecular level, orthosilicate anions derived from MMST metabolism interact with polyanionic glycosaminoglycans such as chondroitin sulfate and hyaluronic acid, stabilizing the proteoglycan network of cartilage and dermis and promoting the retention of water within the extracellular matrix. MMST is partially metabolized in vivo rather than being absorbed intact in its entirety, contributing approximately 50% of the observed serum silicon elevation as intact or closely related species and 10% of elevated urinary silicon, suggesting partial transformation to orthosilicic acid or related monomeric species during transit and metabolism. Additionally, monomeric silicon species competitively inhibit aluminum uptake in the gut and facilitate the formation of urinary hydroxyaluminosilicates, providing a chelation-adjacent mechanism for reducing aluminum bioaccumulation in tissues including the central nervous system.
Clinical Evidence
The pivotal human clinical trial for MMST was a double-blind, crossover RCT (n=22 healthy pre-menopausal women, ages 22–38) that administered 10.5 mg Si/day as MMST for four weeks, with fasting serum silicon and urinary silicon as primary endpoints; both were significantly elevated versus placebo (P ≤ 0.003), confirming absorption and systemic delivery. No statistically significant effects on health, well-being, quality of life scores, or comprehensive serum biochemistry panels were detected, indicating tolerability but also highlighting that short-duration biomarker studies cannot establish clinical efficacy for structural endpoints such as bone density or skin elasticity. A secondary human study reported qualitative and semi-quantitative improvements in skin, nail, and hair parameters and aluminum excretion with oral MMST, but methodological details were insufficient to permit meta-analytic integration. Confidence in MMST's bioavailability is moderate based on replicated pharmacokinetic findings; confidence in specific clinical efficacy outcomes (bone health, skin improvement) remains preliminary and requires validation through adequately powered, long-duration RCTs.
Safety & Interactions
MMST at 10.5 mg Si/day for four weeks was found to be safe in a controlled human trial of pre-menopausal women, with no significant adverse effects on health, well-being, quality of life, or standard serum biochemistry parameters compared to placebo, and EFSA has recognized MMST as a safe novel food ingredient at recommended doses. No specific drug-drug interactions have been formally characterized for MMST in published literature; however, given silicon's ability to form complexes with aluminum-containing compounds, caution is theoretically warranted when co-administering aluminum-based antacids or phosphate binders, as silicon may alter aluminum bioavailability. No contraindications have been established in available clinical data; however, safety in pregnancy, lactation, pediatric populations, and individuals with chronic kidney disease (where silicon excretion may be impaired) has not been evaluated in controlled studies and cannot be presumed from existing evidence. Long-term safety beyond four weeks has not been evaluated in randomized trials, and individuals with impaired renal function should consult a healthcare provider before use given that monomeric silicon is cleared primarily via the kidneys.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
MonomethylsilanetriolMMSTMethylsilanetriolOrganic siliconCH3Si(OH)3
Frequently Asked Questions
What is monomethylsilanetriol (MMST) and how does it differ from other silicon supplements?
MMST is a monomeric organosilicon compound that delivers elemental silicon in a water-soluble, readily absorbed form, distinguishing it from polymeric silica sources (such as silicon dioxide or food silicon from grains) that have low fractional absorption estimated at 2–4%. Clinical pharmacokinetic data show MMST raises fasting serum silicon significantly and is bioavailability-comparable to orthosilicic acid (OSA), making both MMST and OSA the most bioavailable silicon supplement forms currently studied in humans. The monomeric structure is key: polymeric silicon must be depolymerized before absorption, whereas MMST is absorbed largely as a small molecular species, bypassing this limiting step.
What is the recommended dosage of MMST silicon and how long should it be taken?
The maximum clinically studied and regulatory-referenced dose for MMST is 10.5 mg of elemental silicon per day, which in molecular terms corresponds to approximately 21 mg of the MMST compound itself. This dose was used in a four-week double-blind crossover trial that confirmed significant increases in serum and urinary silicon without adverse effects; longer supplementation durations are practiced commercially but lack dedicated long-term RCT data. MMST is typically taken as an oral liquid solution, and no specific food-timing requirement has been established, though the pharmacokinetic trial measured fasting serum levels to standardize baseline conditions.
Does MMST silicon actually work for skin, hair, and nail health?
Preclinical and limited clinical evidence supports MMST's role in skin, hair, and nail improvement through silicon's function as a cofactor in collagen cross-linking and glycosaminoglycan synthesis, both of which are foundational to dermal structure and keratin integrity. One clinical investigation reported improvements in skin surface parameters, nail strength, and hair quality following oral MMST use, and topical MMST has been shown to penetrate viable epidermis and dermis, enabling localized delivery. However, the methodological details of skin-focused trials are not fully published, and large-scale randomized controlled trials with validated dermatological endpoints are lacking, so conclusions should be considered preliminary.
Is monomethylsilanetriol safe to take, and are there any side effects?
At the studied dose of 10.5 mg Si/day for four weeks, MMST produced no significant adverse effects on health, well-being, quality of life, or serum biochemistry compared to placebo in a controlled human trial, and EFSA has recognized it as a safe novel food ingredient at recommended doses. No specific drug interactions have been formally documented, though theoretical caution applies to concurrent use with aluminum-containing medications due to silicon-aluminum complex formation. Safety data are absent for pregnant and lactating individuals, children, and those with chronic kidney disease (since silicon is renally excreted), and these groups should seek medical guidance before use.
Can MMST silicon help remove aluminum from the body?
Silicon, including that provided by MMST, is recognized as an aluminum detoxification agent based on its capacity to form stable hydroxyaluminosilicate complexes in the gastrointestinal tract and in systemic circulation, which are then excreted via urine rather than accumulating in tissues. Research by Exley and colleagues using silicon-rich mineral waters demonstrated reduced urinary aluminum and brain aluminum burden, and MMST-based oral supplementation has been reported to facilitate aluminum excretion in human subjects, though the specific mechanistic and quantitative data for MMST (versus mineral water silicon) are not fully characterized in peer-reviewed publications. This property makes silicon supplementation of interest for individuals with elevated aluminum exposure, though MMST should not replace medical treatment for aluminum toxicity.
How does MMST silicon support bone health differently than other forms of silicon supplementation?
MMST silicon uniquely stabilizes the hydroxylation of proline and lysine residues in procollagen, which are essential for cross-linking collagen fibrils within the bone matrix (osteoid). This molecular mechanism directly strengthens bone structure at the matrix level, whereas other silicon forms may provide less bioavailable support for collagen synthesis. The enhanced connective tissue architecture from MMST contributes to improved bone mineral quality, not just density alone.
Can MMST silicon be beneficial for joint and ligament health during aging or athletic recovery?
Yes, MMST silicon actively promotes neocollagenesis in tendons, ligaments, and cartilage by stabilizing critical amino acid hydroxylation in procollagen. This makes it particularly relevant for individuals experiencing age-related collagen breakdown or those seeking to support ligament and tendon integrity during athletic training and recovery. The strengthening of the extracellular matrix through MMST's mechanism may help maintain structural resilience over time.
What is the bioavailability advantage of MMST compared to other silicon supplement forms?
MMST (monomethylsilanetriol) is a stable, low-molecular-weight silicic acid derivative that demonstrates superior absorption compared to bulky forms like silicon dioxide. Its molecular structure allows it to cross the intestinal barrier more efficiently and reach target tissues where collagen synthesis occurs. This enhanced bioavailability translates to more effective participation in procollagen hydroxylation and connective tissue strengthening at lower doses.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w silicon-from-monomethylsilanetriol-mmst curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
